Biotech Values

[DewDiligence]

Cypher and DES Data from JNJ’s 2Q09 CC

2Q09 CYPHER SALES

US:
$70M, -59% YoY
ASP: -5% YoY
Market share: 14%, -100 basis pts QoQ, -2300 basis pts YoY

Ex-US:
$165M, -23% YoY in constant currencies
Market share: 27%, -200 basis pts QoQ, -300 basis pts YoY

Worldwide total:
$235M, -38% YoY in constant currencies
Market share: 22%, -100 bais pts QoQ, -1100 basis pts YoY


MISCELLANEOUS 2Q09 DES FIGURES

US DES sales by all companies: +2% YoY
US penetration of DES’s in PCI procedures: 74%, flat QoQ, +800 basis pts YoY